PMID- 38088092
OWN - NLM
STAT- MEDLINE
DCOM- 20231216
LR  - 20231216
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 97
DP  - 2023 Dec 13
TI  - [Utility of the Abeona Health(R) app for patient participation in the 
      identification of chemotherapy-induced toxicity according to the CTCAE 
      classification].
LID - e202312108 [pii]
AB  - OBJECTIVE: Since 2003, the National Cancer Institute (NCI) of the United States 
      of America has been one of the world leaders in classifying adverse effects 
      (AEs). Currently, smartphones allow, among many other things, the monitoring of 
      these AEs of chemotherapy from home to improve the safety and quality of life of 
      patients. The aim was to perform a descriptive comparative analysis of the AEs 
      content of the Abeona Health(R) app and the latest version of the CTCAE (Common 
      Terminology Criteria for Adverse Events). METHODS: The Abeona Health(R) app and the 
      CTCAE v5 guide were used. Subsequently, the most recurrent AEs in the existing 
      chemotherapy treatment were analysed according to the NCI and the Spanish Society 
      of Medical Oncology (SEOM) and finally, whether patients could identify them. 
      RESULTS: The CTCAE v5 (collects 837 AEs), where two hundred and twenty-five are 
      signs and symptoms. The NCI classifies fifty-five signs and symptoms as the most 
      recurrent, and the SEOM sixteen, of which fifteen coincide with the NCI. The 
      Abeona Health(R) application has seven AEs, all included in the CTCAE v5. Of these 
      seven, six appear in the NCI lists of most recurrent AEs and four in the SEOM 
      list, all identifiable by the patient. CONCLUSIONS: The Abeona Health(R) app is 
      considered adequate for the patient participation in their self-care, although 
      some fields could be expanded.
FAU - de Miguel Barbero, Carlota
AU  - de Miguel Barbero C
AD  - Escuela Internacional de Doctorado; Universidad de Andorra. Andorra.
AD  - Doctoranda en Salud Digital; Grupo de investigacion en Ciencias de la Salud y 
      Servicios Sanitarios. Universidad de Andorra. Andorra.
FAU - Gea Rodriguez, Elvira
AU  - Gea Rodriguez E
AD  - Escuela Internacional de Doctorado; Universidad de Andorra. Andorra.
AD  - Grupo de investigacion en Ciencias de la Salud y Servicios Sanitarios; Escuela 
      internacional de Doctorado. Universidad de Andorra. Andorra.
FAU - Garcia Cuyas, Francesc
AU  - Garcia Cuyas F
AD  - Escuela Internacional de Doctorado; Universidad de Andorra. Andorra.
AD  - Profesor colaborador como miembro del Grupo de investigacion en Ciencias de la 
      Salud y Servicios Sanitarios; Universidad de Andorra. Andorra.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Utilidad de la app Abeona Health(R) para la participacion del paciente en la 
      identificacion de toxicidad inducida por quimioterapia segun la clasificacion 
      CTCAE.
DEP - 20231213
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Humans
MH  - United States
MH  - *Neoplasms
MH  - Patient Participation
MH  - Quality of Life
MH  - *Mobile Applications
MH  - Spain
MH  - *Antineoplastic Agents/adverse effects
OTO - NOTNLM
OT  - Cancer
OT  - Chemistry
OT  - Clinical Oncology
OT  - Empowerment for health
OT  - Mobile Applications
OT  - Nursing
OT  - Spain
OT  - Telemedicine
OT  - Toxicity
EDAT- 2023/12/13 06:42
MHDA- 2023/12/17 09:43
CRDT- 2023/12/13 04:22
PHST- 2022/11/17 00:00 [received]
PHST- 2023/01/16 00:00 [accepted]
PHST- 2023/12/17 09:43 [medline]
PHST- 2023/12/13 06:42 [pubmed]
PHST- 2023/12/13 04:22 [entrez]
AID - e202312108 [pii]
PST - epublish
SO  - Rev Esp Salud Publica. 2023 Dec 13;97:e202312108.